Coronavirus vaccines may be less effective for Black and Asian recipients, MIT study suggests
Promising results from Moderna, Pfizer, and AstraZeneca's coronavirus vaccines have raised hopes that an end to the pandemic may be in sight. But distribution issues aside, a study from the Massachusetts Institute of Technology out last week is raising further concerns about those vaccines' effectiveness.
After initial human trials, Moderna reported its vaccine to be 94 percent effective in preventing coronavirus transmission, while Pfizer's was 95 percent effective and AstraZeneca's 70 percent. But these vaccines, along with many others still in development, share a potential weakness, MIT researchers report. Researchers used artificial intelligence and machine learning to examine a vaccine similar to these big developers', and found that while less than 0.5 percent of white trial participants didn't respond strongly to the vaccine, nearly 10 percent of Asian participants didn't. This could mean "people of Black or Asian ancestry could have a slightly increased risk of vaccine ineffectiveness," the study's senior author David Gifford said in an article accompanying the study.
A lack of diversity in the vaccine trial pools may have led developers to calibrate the vaccine to a specific version of human genes — white people's genes in particular. But MIT researchers did offer a potential solution: "adding a small number of additional COVID-19 peptides" — strings of amino acids that make up proteins, which in turn make up a coronavirus — "to a given dose of the vaccine," MIT's Computer Science and Artificial Intelligence lab writes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The study's results highlight longstanding trends in health care" and clinical trials, Health IT Analytics notes. Minority groups are often underrepresented in trials, making it less certain how effective vaccines and drugs will be for them and potentially leading to the formulation of vaccines that are tailored for white people. That's especially troubling amid the coronavirus pandemic, as Black and brown people have disproportionately been hospitalized with and died of the virus.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
What to know when planning an awe-inspiring hike on the Inca Trail
The Week Recommends Peru's most famous trail leads to Machu Picchu
By Catherine Garcia, The Week US Published
-
Lead poisoning remains a threat
The Explainer The toxin is built into our lives
By Devika Rao, The Week US Published
-
Should you use a 529 plan? What to know about this college savings option.
The Explainer This tax-advantaged savings account can be used to pay tuition or buy textbooks
By Becca Stanek, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published